BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14513254)

  • 21. A strategy of 'treating through' a prasugrel-induced rash.
    Yang DC; Feldman DN; Kim LK; Minutello RM; Bergman G; Wong SC; Swaminathan RV
    Int J Cardiol; 2013 Oct; 168(4):4381-2. PubMed ID: 23706323
    [No Abstract]   [Full Text] [Related]  

  • 22. [Telaprevir-induced pityriasis rubra pilaris].
    Schmutz JL; Trechot P
    Ann Dermatol Venereol; 2013 May; 140(5):414-5. PubMed ID: 23663723
    [No Abstract]   [Full Text] [Related]  

  • 23. Generalized flare of pustular psoriasis induced by PEGylated interferon-α2b therapy for chronic hepatitis C.
    Wu MC; Lee JY
    Australas J Dermatol; 2012 Nov; 53(4):e69-72. PubMed ID: 23157789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-alpha induced psoriasis in a teenager.
    Mendieta KL; Irfan M; Fernandez Faith E
    Pediatr Dermatol; 2018 Mar; 35(2):e136-e137. PubMed ID: 29575077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolated Bilateral Ear and Scalp Rash After Cytarabine Therapy for Acute Myelogenous Leukemia: A Report and Literature Review.
    Waseem H; Henriquez Felipe C; Hashmi AT; Ansar M; Batool A; Saverimuthu A; Kamholz SL
    Am J Ther; 2019; 26(5):e653-e655. PubMed ID: 30418222
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tetrazepam (Myolastan)-induced exanthema: positive patch tests in 2 cases].
    Ghislain PD; Roussel S; Bouffioux B; Delescluse J
    Ann Dermatol Venereol; 2000 Dec; 127(12):1094-6. PubMed ID: 11173688
    [No Abstract]   [Full Text] [Related]  

  • 27. Cutaneous reactions to interferon and ribavirin.
    Chamberlain AJ; Poon E
    Intern Med J; 2004 Aug; 34(8):519. PubMed ID: 15317557
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute generalized exanthematous pustulosis in a child.
    Sezer E; Sezer T; Koseoglu D; Filiz NO
    Pediatr Dermatol; 2007; 24(1):93-5. PubMed ID: 17300662
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical and immunological features of hepatitis C treatment-associated dermatitis in 36 prospective cases.
    Lübbe J; Kerl K; Negro F; Saurat JH
    Br J Dermatol; 2005 Nov; 153(5):1088-90. PubMed ID: 16225644
    [No Abstract]   [Full Text] [Related]  

  • 30. Diffuse skin reaction in patient with hepatitis B, treated with two different formulations of pegylated interferon.
    Milkiewicz P; Yim C; Pache I; Heathcote J
    Can J Gastroenterol; 2005 Nov; 19(11):677-8. PubMed ID: 16292363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remdesivir-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE)? A case report with review of the literature.
    Heck J; Stichtenoth DO; Mettin R; Jöckel J; Bickel C; Krichevsky B
    Eur J Clin Pharmacol; 2021 Jan; 77(1):141-144. PubMed ID: 32761371
    [No Abstract]   [Full Text] [Related]  

  • 32. Rosacea fulminans related to pegylated interferon alpha-2b and ribavirin therapy.
    Bettoli V; Mantovani L; Boccia S; Virgili A
    Acta Derm Venereol; 2006; 86(3):258-9. PubMed ID: 16710591
    [No Abstract]   [Full Text] [Related]  

  • 33. Interferon-alpha 2b induced facial erythema in a woman with chronic hepatitis C infection.
    Tursen U; Kaya TI; Ikizoglu G
    J Eur Acad Dermatol Venereol; 2002 May; 16(3):285-6. PubMed ID: 12195575
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University Liver Disease Study.
    Ogawa E; Furusyo N; Kajiwara E; Takahashi K; Nomura H; Tanabe Y; Satoh T; Maruyama T; Nakamuta M; Kotoh K; Azuma K; Dohmen K; Shimoda S; Hayashi J;
    J Gastroenterol Hepatol; 2012 Jul; 27(7):1233-40. PubMed ID: 22098185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fixed drug-induced exanthema caused by novorin nose drops].
    Bata Z; Husz S; Dobozy A
    Orv Hetil; 1992 Apr; 133(14):859-60. PubMed ID: 1387931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exacerbation of oral lichen planus lesions during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
    Grossmann Sde M; Teixeira R; de Aguiar MC; do Carmo MA
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):702-6. PubMed ID: 18679075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse response to pegylated interferon therapy in two patients with chronic hepatitis C.
    Thomas WL; Ramos F; Hospenthal DR
    Hawaii Med J; 2003 Aug; 62(8):163-4. PubMed ID: 14533347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catatonia associated with pegylated interferon-α 2b and ribavirin for hepatitis C.
    Quinn D; Kuchler E; Deming P; Arora S
    Psychosomatics; 2012; 53(4):400-1. PubMed ID: 22748752
    [No Abstract]   [Full Text] [Related]  

  • 39. Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C.
    Yurci A; Guven K; Torun E; Gursoy S; Baskol M; Akgun H; Ozbakir O; Yucesoy M
    Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):811-5. PubMed ID: 17700270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pure red-cell aplasia associated with pegylated interferon-alpha-2b plus ribavirin.
    Miura Y; Kami M; Yotsuya R; Toda N; Komatsu T
    Am J Hematol; 2008 Sep; 83(9):758-9. PubMed ID: 18615552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.